Lori Sherman
Overview
Explore the profile of Lori Sherman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DeLuca K, Mick J, Ide A, Lima W, Sherman L, Schaller K, et al.
Elife
. 2021 Dec;
10.
PMID: 34970967
Antibodies are indispensable tools used for a large number of applications in both foundational and translational bioscience research; however, there are drawbacks to using traditional antibodies generated in animals. These...
2.
Boonyaratanakornkit V, McGowan E, Sherman L, Mancini M, Cheskis B, Edwards D
Mol Endocrinol
. 2006 Dec;
21(2):359-75.
PMID: 17138644
Human progesterone receptor (PR) contains a motif that interacts with the SH3 domain of Src and mediates rapid activation of Src and downstream MAPK (Erk-1/-2) without relying on the transcriptional...
3.
Roemer S, Donham D, Sherman L, Pon V, Edwards D, Churchill M
Mol Endocrinol
. 2006 Aug;
20(12):3042-52.
PMID: 16931575
The DNA binding domain (DBD) of nuclear hormone receptors contains a highly conserved globular domain and a less conserved carboxyl-terminal extension (CTE). Despite previous observations that the CTEs of some...
4.
Wardell S, Kwok S, Sherman L, Hodges R, Edwards D
Mol Cell Biol
. 2005 Oct;
25(20):8792-808.
PMID: 16199860
We previously identified a small basic leucine zipper (bZIP) protein, Jun dimerization protein 2 (JDP-2), that acts as a coregulator of the N-terminal transcriptional activation domain of progesterone receptor (PR)....
5.
Press M, Spaulding B, Groshen S, Kaminsky D, Hagerty M, Sherman L, et al.
Steroids
. 2002 Jul;
67(9):799-813.
PMID: 12123792
Monoclonal antibodies directed against human estrogen receptor (ER) and progesterone receptor (PR) have been used extensively for biochemical and immunohistochemical detection of receptors independent of hormone-binding assays. These antibodies have...